Welcome to our dedicated page for Petmed Express news (Ticker: PETS), a resource for investors and traders seeking the latest updates and insights on Petmed Express stock.
PetMed Express, Inc. reports developments tied to its PetMeds pet pharmacy platform, its PetCareRx business, and the sale of prescription and non-prescription pet medications, preventatives, health products, and supplies. The company serves pet owners through direct-to-consumer channels and has announced distribution partnerships that extend pet pharmacy offerings across retail and digital channels.
Recurring news themes include product assortments focused on pet wellness, fiscal results and financial reporting updates, Nasdaq listing-rule communications related to periodic filings, board and audit committee changes, shareholder rights plan actions, and responses to unsolicited acquisition proposals. Coverage also reflects the company's positioning as a national pet pharmacy and pet health products retailer.
PetMed Express reported a strong performance for Q2 2020 with net sales reaching $75.4 million, up 7.9% from $69.9 million in Q2 2019. The net income rose 26.2% to $8.4 million or $0.42 per diluted share. Reorder sales also saw a significant increase of 9.6% to $67.8 million. With gross margins improving from 27.8% to 30.5%, the company is set to enhance its digital presence by redesigning its website and mobile app. A quarterly dividend of $0.28 per share was declared, payable on November 20, 2020.
PetMed Express (NASDAQ: PETS) is scheduled to announce its financial results for Q2 2020 on October 26, 2020, at 8:00 A.M. ET. CEO Menderes Akdag will host a conference call at 8:30 A.M. ET to discuss these results. The call is public and can be accessed at (888) 455-1758 with the passcode PETMEDS. A replay will be available from 10:00 A.M. ET on the same day until November 9, 2020. PetMed Express is recognized as America’s Largest and Most Trusted Pet Pharmacy, providing prescription and non-prescription pet medications directly to consumers.
PetMed Express (NASDAQ: PETS) reported a 20% increase in net sales for the first quarter ended June 30, 2020, totaling $96.2 million, up from $80.0 million in the same period last year. Net income rose 47% to $7.8 million, or $0.39 diluted per share. New order sales grew 29% to $15.8 million, while reorder sales increased 19% to $80.4 million. The company acquired 186,000 new customers, enhancing its average order size to $89. A quarterly dividend of $0.28 per share has been declared, payable on August 7, 2020.
PetMed Express (NASDAQ: PETS) will report its financial results for Q1 2020 on July 20, 2020, at 8:00 A.M. ET. A conference call led by CEO Menderes Akdag will follow at 8:30 A.M. ET, accessible via phone at (888) 455-1758 or (203) 827-7025 with passcode PETMEDS. For those unable to attend live, a replay will be available from 10:00 A.M. ET on the same day until August 3, 2020.
Founded in 1996, PetMed Express is a leading online pet pharmacy, providing a range of medications and health products for pets.